Drug Shortage Report for TEVA-CHLOROQUINE
Report ID | 99447 |
Drug Identification Number | 00021261 |
Brand name | TEVA-CHLOROQUINE |
Common or Proper name | CHLOROQUINE 250MG TABLETS |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CHLOROQUINE DIPHOSPHATE |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | P01BA |
ATC description | ANTIMALARIALS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | |
Actual start date | 2019-11-21 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-07-10 |
Company comments | Need to source and validate an alternate API Supplier |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-07-10 | French | Compare |
v4 | 2020-07-10 | English | Compare |
v3 | 2019-11-22 | English | Compare |
v2 | 2019-11-21 | French | Compare |
v1 | 2019-11-21 | English | Compare |
Showing 1 to 5 of 5